{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:19:49Z","timestamp":1775801989828,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004442","name":"National Science Centre","doi-asserted-by":"crossref","award":["2011\/03\/B\/NZ3\/04549"],"award-info":[{"award-number":["2011\/03\/B\/NZ3\/04549"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.neuint.2016.01.005","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T22:01:17Z","timestamp":1453413677000},"page":"103-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The mechanisms regulating cyclin-dependent kinase 5 in hippocampus during systemic inflammatory response: The effect on inflammatory gene expression"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7541-1571","authenticated-orcid":false,"given":"Grzegorz A.","family":"Czapski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"G\u0105ssowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Wilkaniec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Chalimoniuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna B.","family":"Strosznajder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Adamczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2016.01.005_bib1","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.bcp.2012.06.027","article-title":"Extraneuronal activities and regulatory mechanisms of the atypical cyclin-dependent kinase Cdk5","volume":"84","author":"Arif","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuint.2016.01.005_bib2","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1073\/pnas.1011275108","article-title":"Phosphorylation of glutamyl-prolyl tRNA synthetase by cyclin-dependent kinase 5 dictates transcript-selective translational control","volume":"108","author":"Arif","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2016.01.005_bib3","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1476-5381.2011.01309.x","article-title":"Roscovitine blocks leukocyte extravasation by inhibition of cyclin-dependent kinases 5 and 9","volume":"163","author":"Berberich","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2016.01.005_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuron.2010.08.023","article-title":"Regulation of tau pathology by the microglial fractalkine receptor","volume":"68","author":"Bhaskar","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2016.01.005_bib5","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3233\/JAD-131784","article-title":"TFP5, a peptide derived from p35, a Cdk5 neuronal activator, rescues cortical neurons from glucose toxicity","volume":"39","author":"Binukumar","year":"2014","journal-title":"J.\u00a0Alzheimer's Dis."},{"key":"10.1016\/j.neuint.2016.01.005_bib6","first-page":"161","article-title":"Cyclin-dependent kinases and cyclin-dependent kinase inhibitors. Detection methods and activity measurements","volume":"124","author":"Brooks","year":"2001","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neuint.2016.01.005_bib7","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/jnr.23576","article-title":"Cyclin-Dependent kinase 5 targeting prevents beta-Amyloid aggregation involving glycogen synthase kinase 3beta and phosphatases","volume":"93","author":"Castro-Alvarez","year":"2015","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuint.2016.01.005_bib8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.nbd.2011.10.011","article-title":"Striatal inhibition of calpains prevents levodopa-induced neurochemical changes and abnormal involuntary movements in the hemiparkinsonian rat model","volume":"45","author":"Chagniel","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2016.01.005_bib9","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1038\/cddis.2011.2","article-title":"Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease","volume":"2","author":"Crews","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuint.2016.01.005_bib10","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.neuint.2013.01.020","article-title":"Expression and activity of PARP family members in the hippocampus during systemic inflammation: their role in the regulation of prooxidative genes","volume":"62","author":"Czapski","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2016.01.005_bib11","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/jnr.21294","article-title":"Role of nitric oxide in the brain during lipopolysaccharide-evoked systemic inflammation","volume":"85","author":"Czapski","year":"2007","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuint.2016.01.005_bib12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.neuint.2006.06.006","article-title":"Poly(ADP-ribose) polymerase-1 inhibition protects the brain against systemic inflammation","volume":"49","author":"Czapski","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2016.01.005_bib13","first-page":"643","article-title":"Inhibition of nitric oxide synthase prevents energy failure and oxidative damage evoked in the brain by lipopolysaccharide","volume":"56","author":"Czapski","year":"2004","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.neuint.2016.01.005_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brainres.2010.07.096","article-title":"Systemic administration of lipopolysaccharide induces molecular and morphological alterations in the hippocampus","volume":"1356","author":"Czapski","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2016.01.005_bib15","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.febslet.2011.03.058","article-title":"Alterations of cyclin dependent kinase 5 expression and phosphorylation in amyloid precursor protein (APP)-transfected PC12 cells","volume":"585","author":"Czapski","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuint.2016.01.005_bib16","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1016\/j.febslet.2013.07.053","article-title":"Extracellular alpha-synuclein induces calpain-dependent overactivation of cyclin-dependent kinase 5 in\u00a0vitro","volume":"587","author":"Czapski","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuint.2016.01.005_bib17","doi-asserted-by":"crossref","first-page":"11622","DOI":"10.1523\/JNEUROSCI.3153-08.2008","article-title":"Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model","volume":"28","author":"Ding","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2016.01.005_bib18","doi-asserted-by":"crossref","first-page":"C742","DOI":"10.1152\/ajpcell.00138.2009","article-title":"Inhibition of CDKS by roscovitine suppressed LPS-induced *NO production through inhibiting NFkappaB activation and BH4 biosynthesis in macrophages","volume":"297","author":"Du","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuint.2016.01.005_bib19","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.7150\/ijbs.4679","article-title":"Interleukin-6, a major cytokine in the central nervous system","volume":"8","author":"Erta","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.neuint.2016.01.005_bib20","doi-asserted-by":"crossref","first-page":"24977","DOI":"10.1074\/jbc.M000808200","article-title":"Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase II inhibits tau's ability to promote microtubule assembly","volume":"275","author":"Evans","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2016.01.005_bib21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/35074516","article-title":"ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1","volume":"3","author":"Harada","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neuint.2016.01.005_bib22","first-page":"165","article-title":"The role of pharmacokinetics and pharmacodynamics in early drug development with reference to the cyclin-dependent kinase (Cdk) inhibitor - roscovitine","volume":"11","author":"Hassan","year":"2011","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"10.1016\/j.neuint.2016.01.005_bib23","series-title":"Cyclin Dependent Kinase 5 (Cdk5)","article-title":"The kinase activity of Cdk5 and its regulation","author":"Hisanaga","year":"2008"},{"key":"10.1016\/j.neuint.2016.01.005_bib24","first-page":"321","article-title":"Systemic administration of lipopolysaccharide impairs glutathione redox state and object recognition in male mice. The effect of PARP-1 inhibitor","volume":"47","author":"Jacewicz","year":"2009","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.neuint.2016.01.005_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2184.2009.00584.x","article-title":"Inhibition of cyclin-dependent kinases by olomoucine and roscovitine reduces lipopolysaccharide-induced inflammatory responses via down-regulation of nuclear factor kappaB","volume":"42","author":"Jhou","year":"2009","journal-title":"Cell Prolif."},{"key":"10.1016\/j.neuint.2016.01.005_bib70","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.4103\/1673-5374.141779","article-title":"Selective CDK inhibitors: promising candidates for future clinical traumatic brain injury trials","volume":"9","author":"Kabadi","year":"2014","journal-title":"Neural. Regen. Res."},{"key":"10.1016\/j.neuint.2016.01.005_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/jcbfm.2011.117","article-title":"Selective CDK inhibitor limits neuroinflammation and progressive neurodegeneration after brain trauma","volume":"32","author":"Kabadi","year":"2012","journal-title":"J.\u00a0Cereb. Blood Flow Metabol."},{"key":"10.1016\/j.neuint.2016.01.005_bib27","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s10571-009-9410-6","article-title":"Targeting Cdk5 activity in neuronal degeneration and regeneration","volume":"29","author":"Kanungo","year":"2009","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2016.01.005_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fnmol.2014.00065","article-title":"Physiological and pathological phosphorylation of tau by Cdk5","volume":"7","author":"Kimura","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuint.2016.01.005_bib29","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2353\/ajpath.2006.051232","article-title":"Genetically augmenting Abeta42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice","volume":"168","author":"Kitazawa","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuint.2016.01.005_bib30","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1523\/JNEUROSCI.2868-05.2005","article-title":"Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease","volume":"25","author":"Kitazawa","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2016.01.005_bib31","doi-asserted-by":"crossref","first-page":"17166","DOI":"10.1074\/jbc.M907757199","article-title":"Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25","volume":"275","author":"Kusakawa","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2016.01.005_bib32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1742-2094-7-56","article-title":"LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice","volume":"7","author":"Lee","year":"2010","journal-title":"J.\u00a0Neuroinflam."},{"key":"10.1016\/j.neuint.2016.01.005_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbrc.2014.03.118","article-title":"Acetylation of cyclin-dependent kinase 5 is mediated by GCN5","volume":"447","author":"Lee","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2016.01.005_bib34","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/jcp.22782","article-title":"Cdk5 mediates vimentin Ser56 phosphorylation during GTP-induced secretion by neutrophils","volume":"227","author":"Lee","year":"2012","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.neuint.2016.01.005_bib35","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/eji.200939664","article-title":"The cyclin-dependent kinase inhibitor R-roscovitine down-regulates Mcl-1 to override pro-inflammatory signalling and drive neutrophil apoptosis","volume":"40","author":"Leitch","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.neuint.2016.01.005_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pneurobio.2011.03.006","article-title":"Cdk5: multitasking between physiological and pathological conditions","volume":"94","author":"Lopes","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2016.01.005_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4161\/cc.8.1.7506","article-title":"Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-beta and prion peptides","volume":"8","author":"Lopes","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.neuint.2016.01.005_bib38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1515\/rns.2011.015","article-title":"Silencing of CDK5 as potential therapy for Alzheimer's disease","volume":"22","author":"Lopez-Tobon","year":"2011","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neuint.2016.01.005_bib39","doi-asserted-by":"crossref","first-page":"e12117","DOI":"10.1371\/journal.pone.0012117","article-title":"Delayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits in\u00a0vivo CDK5 activity increase in animal stroke models","volume":"5","author":"Menn","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2016.01.005_bib40","doi-asserted-by":"crossref","first-page":"30142","DOI":"10.1074\/jbc.M104265200","article-title":"Overexpression of macrophage colony-stimulating factor receptor on microglial cells induces an inflammatory response","volume":"276","author":"Mitrasinovic","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2016.01.005_bib41","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1038\/sj.emboj.7600237","article-title":"A\u00a0novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons","volume":"23","author":"Morfini","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.neuint.2016.01.005_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neuroscience.2011.05.055","article-title":"Cyclin-dependent kinase 5 with phosphorylation of tyrosine 15 residue is enriched in striatal matrix compartment in adult mice","volume":"189","author":"Morigaki","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2016.01.005_bib43","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2353\/ajpath.2008.070693","article-title":"Neurodegeneration and neuroinflammation in cdk5\/p25-inducible mice: a model for hippocampal sclerosis and neocortical degeneration","volume":"172","author":"Muyllaert","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuint.2016.01.005_bib44","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.neuropharm.2012.05.011","article-title":"The novel calpain inhibitor A-705253 prevents stress-induced tau hyperphosphorylation in\u00a0vitro and in\u00a0vivo","volume":"63","author":"Nikkel","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2016.01.005_bib45","doi-asserted-by":"crossref","first-page":"24057","DOI":"10.1074\/jbc.273.37.24057","article-title":"the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway","volume":"273","author":"Patrick","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2016.01.005_bib46","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/45159","article-title":"Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration","volume":"402","author":"Patrick","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2016.01.005_bib47","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1073\/pnas.0912718107","article-title":"No difference in kinetics of tau or histone phosphorylation by CDK5\/p25 versus CDK5\/p35 in\u00a0vitro","volume":"107","author":"Peterson","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2016.01.005_bib48","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1074\/jbc.272.9.5703","article-title":"Identification of functional domains in the neuronal Cdk5 activator protein","volume":"272","author":"Poon","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2016.01.005_bib49","doi-asserted-by":"crossref","first-page":"14330","DOI":"10.1073\/pnas.1105172108","article-title":"S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide","volume":"108","author":"Qu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2016.01.005_bib50","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4161\/pri.21250","article-title":"S-nitrosylation of Cdk5: potential implications in amyloid-beta-related neurotoxicity in Alzheimer disease","volume":"6","author":"Qu","year":"2012","journal-title":"Prion"},{"key":"10.1016\/j.neuint.2016.01.005_bib51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yexcr.2004.01.002","article-title":"Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5\/p35 pathway","volume":"295","author":"Quintanilla","year":"2004","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.neuint.2016.01.005_bib52","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1460-9568.2011.07764.x","article-title":"Lipopolysaccharide-induced tau phosphorylation and kinase activity\u2013modulation, but not mediation, by corticotropin-releasing factor receptors","volume":"34","author":"Roe","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2016.01.005_bib53","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000074543","article-title":"Cdk7 functions as a cdk5 activating kinase in brain","volume":"13","author":"Rosales","year":"2003","journal-title":"Cell. Physiology Biochem."},{"key":"10.1016\/j.neuint.2016.01.005_bib54","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.phrs.2008.05.010","article-title":"Age-dependent pharmacokinetics and effect of roscovitine on Cdk5 and Erk1\/2 in the rat brain","volume":"58","author":"Sallam","year":"2008","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuint.2016.01.005_bib55","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.smim.2013.11.002","article-title":"Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities","volume":"26","author":"Scheller","year":"2014","journal-title":"Sem. Immunol."},{"key":"10.1016\/j.neuint.2016.01.005_bib56","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jchemneu.2005.07.003","article-title":"Systemic inflammation induces apoptosis with variable vulnerability of different brain regions","volume":"30","author":"Semmler","year":"2005","journal-title":"J.\u00a0Chem. Neuroanat."},{"key":"10.1016\/j.neuint.2016.01.005_bib57","doi-asserted-by":"crossref","first-page":"11156","DOI":"10.1073\/pnas.96.20.11156","article-title":"Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation","volume":"96","author":"Sharma","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2016.01.005_bib58","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1074\/jbc.M109324200","article-title":"Phosphorylation of MEK1 by cdk5\/p35 down-regulates the mitogen-activated protein kinase pathway","volume":"277","author":"Sharma","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2016.01.005_bib59","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00280-007-0431-x","article-title":"Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in\u00a0vivo and in\u00a0vitro","volume":"60","author":"Song","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.neuint.2016.01.005_bib60","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1523\/JNEUROSCI.5177-11.2012","article-title":"Cdk5\/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration","volume":"32","author":"Sundaram","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2016.01.005_bib61","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2353\/ajpath.2010.081158","article-title":"Conditional deletion of neuronal cyclin-dependent kinase 5 in developing forebrain results in microglial activation and neurodegeneration","volume":"176","author":"Takahashi","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuint.2016.01.005_bib62","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1097-2765(01)00343-4","article-title":"Structure and regulation of the CDK5-p25(nck5a) complex","volume":"8","author":"Tarricone","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuint.2016.01.005_bib63","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1074\/jbc.M805052200","article-title":"Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35","volume":"284","author":"Utreras","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2016.01.005_bib64","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejps.2005.02.001","article-title":"Tissue distribution, pharmacokinetics and identification of roscovitine metabolites in rat","volume":"25","author":"Vita","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.neuint.2016.01.005_bib65","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1523\/JNEUROSCI.5245-07.2008","article-title":"Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing","volume":"28","author":"Wen","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2016.01.005_bib66","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fncel.2013.00012","article-title":"Dopamine signaling negatively regulates striatal phosphorylation of Cdk5 at tyrosine 15 in mice","volume":"7","author":"Yamamura","year":"2013","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.neuint.2016.01.005_bib67","doi-asserted-by":"crossref","first-page":"14366","DOI":"10.1523\/JNEUROSCI.3899-10.2010","article-title":"S-nitrosylation of cyclin-dependent kinase 5 (cdk5) regulates its kinase activity and dendrite growth during neuronal development","volume":"30","author":"Zhang","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2016.01.005_bib68","doi-asserted-by":"crossref","first-page":"e87788","DOI":"10.1371\/journal.pone.0087788","article-title":"ERK MAP kinase activation in spinal cord regulates phosphorylation of Cdk5 at serine 159 and contributes to peripheral inflammation induced pain\/hypersensitivity","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2016.01.005_bib69","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0896-6273(00)81200-3","article-title":"Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth","volume":"26","author":"Zukerberg","year":"2000","journal-title":"Neuron"}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018616300055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018616300055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T10:25:49Z","timestamp":1589624749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018616300055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":70,"alternative-id":["S0197018616300055"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2016.01.005","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mechanisms regulating cyclin-dependent kinase 5 in hippocampus during systemic inflammatory response: The effect on inflammatory gene expression","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2016.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}